Analysis reveals that 22% of early-onset neonatal sepsis is due to carbapenem-resistant Acinetobacter in southern Pakistan, suggesting urgent need for new antibiotics.
Key Points
Acinetobacter spp emerged as the leading pathogen causing early-onset neonatal sepsis, comprising 22% of cases.
Among carbapenem-resistant Acinetobacter, 72% were multidrug resistant, highlighting severe treatment challenges.
Data analysis involved blood cultures from over 45,000 neonates processed in a central laboratory from 2018 to 2022.
High levels of drug resistance in pathogens call for further research into effective treatment options in neonatal care.